Delaware Medical Marijuana Program

Delaware's medical cannabis program has operated since 2011 and transferred to the Office of the Marijuana Commissioner in January 2025. Even with recreational sales underway, medical patients keep significant advantages.

Last verified: March 2026

Program History and the OMC Transfer

Delaware established its medical marijuana program through the Delaware Medical Marijuana Act (SB 17) in May 2011. For over a decade, the Division of Public Health administered the program, issuing patient cards and overseeing compassion centers.

When recreational cannabis was legalized through HB 1 and HB 2 in 2023, the state created the Office of the Marijuana Commissioner (OMC) to regulate all cannabis activity. HB 425 formally transferred medical program oversight from the Division of Public Health to the OMC, effective January 2025. Commissioner Joshua Sanderlin, sworn in May 16, 2025, now oversees both medical and adult-use programs.

HB 285: The Qualifying Conditions Overhaul

One of the most significant recent changes came through HB 285, effective July 1, 2024. This bill eliminated Delaware's fixed list of qualifying conditions entirely. Licensed practitioners now have full discretion to certify any patient with any diagnosed medical condition they believe could benefit from cannabis therapy. Additionally, patients aged 65 and older can self-certify without a practitioner recommendation.

This change mirrors a broader national trend — states like Oklahoma and Missouri already allowed broad provider discretion, and Delaware followed suit to reduce barriers for patients who need access.

Why Keep a Medical Card After Legalization?

With recreational sales underway since August 2025, many patients wonder whether a medical card is still worth the effort. The answer for most patients is yes, and by a wide margin:

  • Higher possession limit: Medical patients may possess up to 6 ounces of cannabis flower, compared to the 1-ounce recreational limit.
  • Tax exemption: Medical purchases are exempt from the 15% Retail Marijuana Tax. For regular consumers, this saves hundreds of dollars annually.
  • Employment protections: Medical cardholders have additional workplace protections that recreational users do not.
  • Reciprocity: Delaware's medical card is recognized in many other states with reciprocity programs.

Patient Numbers: The Post-Legalization Decline

Delaware's medical patient count peaked at approximately 28,000 in late 2023, shortly after recreational legalization was signed. As of February 2026, enrollment has fallen to 14,971 — a 46% decline. This mirrors trends in every state that adds recreational access: casual users switch to rec purchases, while patients with serious conditions keep their cards for the tax and possession advantages.

Despite the patient decline, medical sales remain strong. In the first seven months of recreational sales (August 2025 through February 2026), medical revenue ($43.1M) outpaced recreational ($29.3M), reflecting the loyalty and spending patterns of the remaining patient base.

Contact the OMC

Regulator Office of the Marijuana Commissioner (OMC)
Commissioner Joshua Sanderlin (sworn May 16, 2025)
Address 1128 S. Bradford St, Dover, DE 19904
Phone (302) 244-3662
Patient Portal delaware.biotrackthc.net/patients/actions/